Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors.
Jing ZhangNational Pharmaceutical Engineering Center for Solid Preparation of Chinese Herbal Medicine, State Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Medicine, Innovation and Entrepreneurship College, Jiangxi University of Chinese Medicine, Nanchang 330006, China.ORCID 0000-0002-6313-5741
Wenhao JiangNational Pharmaceutical Engineering Center for Solid Preparation of Chinese Herbal Medicine, State Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Medicine, Innovation and Entrepreneurship College, Jiangxi University of Chinese Medicine, Nanchang 330006, China.
Lei HuNational Pharmaceutical Engineering Center for Solid Preparation of Chinese Herbal Medicine, State Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Medicine, Innovation and Entrepreneurship College, Jiangxi University of Chinese Medicine, Nanchang 330006, China.
Qing DuNational Pharmaceutical Engineering Center for Solid Preparation of Chinese Herbal Medicine, State Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Medicine, Innovation and Entrepreneurship College, Jiangxi University of Chinese Medicine, Nanchang 330006, China.
Nina FilipczakCenter for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, MA 02115, USA.ORCID 0000-0001-9285-8298
Satya Siva Kishan YalamartyCenter for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, MA 02115, USA.
Xiang LiNational Pharmaceutical Engineering Center for Solid Preparation of Chinese Herbal Medicine, State Key Laboratory for the Modernization of Classical and Famous Prescriptions of Chinese Medicine, Innovation and Entrepreneurship College, Jiangxi University of Chinese Medicine, Nanchang 330006, China.ORCID 0000-0003-1526-6103
Funding
Jiangxi Provincial Department of Education GJJ2400823Jiangxi Provincial Department of Science and Technology 20232ACB206062National Natural Science Foundation of China 82260695Science and Technology Planning Project of Jiangxi Provincial Administration of Traditional Chinese Medicine 2024B0160
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
breast cancerPDA@MnO2photothermal therapysurvivin siRNA
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Construction and Characterization of PDA@MnO · full record | Socratic